These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9452429)

  • 1. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C; Bates EE; Arrigo AP
    J Biol Chem; 1998 Feb; 273(6):3180-91. PubMed ID: 9452429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S; Perrin C; Akari H; Strebel K
    J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.
    Li X; Josef J; Marasco WA
    Biochem Biophys Res Commun; 2001 Aug; 286(3):587-94. PubMed ID: 11511100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii.
    Sahni SK; Van Antwerp DJ; Eremeeva ME; Silverman DJ; Marder VJ; Sporn LA
    Infect Immun; 1998 May; 66(5):1827-33. PubMed ID: 9573057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFkappa B-dependent transcriptional activation during heat shock recovery. Thermolability of the NF-kappaB.Ikappa B complex.
    Kretz-Remy C; Munsch B; Arrigo AP
    J Biol Chem; 2001 Nov; 276(47):43723-33. PubMed ID: 11559696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
    Yin L; Laevsky G; Giardina C
    J Biol Chem; 2001 Nov; 276(48):44641-6. PubMed ID: 11572859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
    Qin Z; Wang Y; Chasea TN
    Brain Res Mol Brain Res; 2000 Sep; 80(2):111-22. PubMed ID: 11038244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kappaB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region.
    de Maisieres PD; Baudoux-Tebache L; Merville MP; Rentier B; Bours V; Piette J
    J Biol Chem; 1998 May; 273(22):13636-44. PubMed ID: 9593702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA; Owens MW; Grisham MB
    Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.
    Page S; Fischer C; Baumgartner B; Haas M; Kreusel U; Loidl G; Hayn M; Ziegler-Heitbrock HW; Neumeier D; Brand K
    J Biol Chem; 1999 Apr; 274(17):11611-8. PubMed ID: 10206970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.
    Jacqué JM; Fernández B; Arenzana-Seisdedos F; Thomas D; Baleux F; Virelizier JL; Bachelerie F
    J Virol; 1996 May; 70(5):2930-8. PubMed ID: 8627768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
    J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
    Maggirwar SB; Harhaj E; Sun SC
    Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
    Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
    Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
    Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
    Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
    Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS
    Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.